Cambridge Investment Research Advisors, Inc. Heron Therapeutics, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 11,667 shares of HRTX stock, worth $13,067. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,667

Previous 14,867 21.52%

Holding current value

$13,067

Previous $52,000 55.77%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$1.73 - $3.67 $5,536 - $11,744	-3,200 Reduced 21.52%	11,667 $23,000
Q2 2024 Jul 26, 2024	BUY	$2.32 - $3.86 $9,280 - $15,440	4,000 Added 36.81%	14,867 $52,000
Q1 2024 Apr 24, 2024	SELL	$1.71 - $3.06 $1,710 - $3,060	-1,000 Reduced 8.43%	10,867 $30,000
Q4 2023 Feb 09, 2024	SELL	$0.54 - $1.82 $2,025 - $6,825	-3,750 Reduced 24.01%	11,867 $20,000
Q3 2023 Oct 24, 2023	SELL	$0.97 - $1.8 $1,843 - $3,420	-1,900 Reduced 10.85%	15,617 $16,000
Q2 2023 Jul 13, 2023	SELL	$1.11 - $2.88 $555 - $1,440	-500 Reduced 2.78%	17,517 $20,000
Q1 2023 May 11, 2023	BUY	$1.51 - $3.25 $1,057 - $2,275	700 Added 4.04%	18,017 $27,000
Q4 2022 Feb 08, 2023	SELL	$2.25 - $4.67 $2,250 - $4,670	-1,000 Reduced 5.46%	17,317 $43,000
Q2 2022 Jul 13, 2022	SELL	$2.3 - $6.29 $3,449 - $9,435	-1,500 Reduced 7.57%	18,317 $51,000
Q1 2022 May 12, 2022	BUY	$4.63 - $9.94 $189 - $407	41 Added 0.21%	19,817 $113,000
Q4 2021 Feb 03, 2022	BUY	$8.35 - $12.6 $37,909 - $57,204	4,540 Added 29.8%	19,776 $180,000
Q3 2021 Nov 02, 2021	BUY	$10.13 - $15.0 $314 - $465	31 Added 0.2%	15,236 $162,000
Q2 2021 Aug 10, 2021	BUY	$13.27 - $18.48 $201,770 - $280,988	15,205 New	15,205 $235,000

Others Institutions Holding HRTX

# of Institutions

180

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $133M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account

Cambridge Investment Research Advisors, Inc. Heron Therapeutics, Inc. Transaction History